P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA
B. Derman,
J. Rosenblatt,
D. Avigan,
A. Major,
M. Rampurwala,
D. Barnidge,
A. Stefka,
K. Jiang,
A. Jakubowiak
Affiliations
B. Derman
1 Section of Hematology/Oncology, University of Chicago, Chicago
J. Rosenblatt
2 Beth Israel Deaconess Medical Center, Boston
D. Avigan
2 Beth Israel Deaconess Medical Center, Boston
A. Major
1 Section of Hematology/Oncology, University of Chicago, Chicago
M. Rampurwala
1 Section of Hematology/Oncology, University of Chicago, Chicago
D. Barnidge
3 The Binding Site Group, Rochester, MN, United States of America
A. Stefka
1 Section of Hematology/Oncology, University of Chicago, Chicago
K. Jiang
1 Section of Hematology/Oncology, University of Chicago, Chicago
A. Jakubowiak
1 Section of Hematology/Oncology, University of Chicago, Chicago
